BlueWhale Bio, Inc.

About BlueWhale Bio, Inc.

BlueWhale Bio, Inc. is dedicated to accelerating the growth and adoption of cell-based therapies, aiming to deliver potent cell therapies faster and more reliably through innovative solutions like Synecta™ Activation and Expansion.

Products & Services

Synecta™ T1:A product focused on cell therapy activation and expansion.

Specialties

Cell-based Therapies Cell Activation and Expansion CAR-engineered Cell Proliferation Immune Cell Activation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 18000000 MR: - FA: $18 million FAN: 18000000	D: 2023-09-07 FD: 2023-09-07	4 investors

Seed Latest

2023-09-07

$18.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Peter Keller

Chief Executive Officer

M

Marc Better

Acting Chief Technology Officer

J

Joseph Dang

Sr. Director, Marketing

V

Victor Carpio

Director, Analytical Development and Quality Control

G

Gil Joseph

Director, Process Development

P

Paula Cannon

PhD

View 11 more team members with Pro

Unlock Full Team Directory

Recent News